[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX2023014611A - Especies, cepas y composiciones de bacterias lacticas capaces de modular la oxigenacion corporal mediante el aumento de los niveles de subunidad alfa del factor 1 inducible por hipoxia (hif-1a). - Google Patents

Especies, cepas y composiciones de bacterias lacticas capaces de modular la oxigenacion corporal mediante el aumento de los niveles de subunidad alfa del factor 1 inducible por hipoxia (hif-1a).

Info

Publication number
MX2023014611A
MX2023014611A MX2023014611A MX2023014611A MX2023014611A MX 2023014611 A MX2023014611 A MX 2023014611A MX 2023014611 A MX2023014611 A MX 2023014611A MX 2023014611 A MX2023014611 A MX 2023014611A MX 2023014611 A MX2023014611 A MX 2023014611A
Authority
MX
Mexico
Prior art keywords
hypoxia
strains
compositions
lactic acid
acid bacteria
Prior art date
Application number
MX2023014611A
Other languages
English (en)
Inventor
Simone Claudio De
Original Assignee
Simone Claudio De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simone Claudio De filed Critical Simone Claudio De
Publication of MX2023014611A publication Critical patent/MX2023014611A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/23—Lactobacillus acidophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/24—Lactobacillus brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)

Abstract

La invención se refiere a especies, cepas y composiciones particulares de bacterias lácticas capaces de aumentar los niveles celulares del factor inducible por hipoxia HIF-1a para el mantenimiento o la mejora de la normoxia en condiciones inductoras de hipoxia tales como, por ejemplo, el esfuerzo físico, el letargo, la fatiga crónica, la deficiencia de oxígeno, los viajes más allá de los límites de la atmósfera terrestre, el estrés oxidativo de los globos oculares y el submarinismo, o para el tratamiento de la hipoxia en condiciones inductoras de hipoxia como las enfermedades neurodegenerativas, las implicaciones pulmonares asociadas a la insuficiencia respiratoria, la hipoxia-isquemia neonatal, la isquemia miocárdica, los trastornos metabólicos, las enfermedades cardíacas y renales crónicas, los trastornos reproductivos como la preeclampsia y la endometriosis, la exacerbación de los temblores posturales y cinéticos y la hipoxia cerebral.
MX2023014611A 2021-07-09 2022-06-17 Especies, cepas y composiciones de bacterias lacticas capaces de modular la oxigenacion corporal mediante el aumento de los niveles de subunidad alfa del factor 1 inducible por hipoxia (hif-1a). MX2023014611A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT202100018152 2021-07-09
PCT/IB2022/055644 WO2023281335A1 (en) 2021-07-09 2022-06-17 SPECIES, STRAINS AND COMPOSITIONS OF LACTIC ACID BACTERIA CAPABLE OF MODULATING BODY OXYGENATION BY INCREASING HIF-1α LEVELS

Publications (1)

Publication Number Publication Date
MX2023014611A true MX2023014611A (es) 2024-03-01

Family

ID=78086653

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023014611A MX2023014611A (es) 2021-07-09 2022-06-17 Especies, cepas y composiciones de bacterias lacticas capaces de modular la oxigenacion corporal mediante el aumento de los niveles de subunidad alfa del factor 1 inducible por hipoxia (hif-1a).

Country Status (9)

Country Link
EP (1) EP4366750A1 (es)
JP (1) JP2024524544A (es)
KR (1) KR20240035481A (es)
CN (1) CN117915934A (es)
AU (1) AU2022305845A1 (es)
CA (1) CA3223348A1 (es)
CO (1) CO2024000934A2 (es)
MX (1) MX2023014611A (es)
WO (1) WO2023281335A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240143043A (ko) * 2023-03-23 2024-10-02 동아대학교 산학협력단 Pdh 억제제의 신경병증 치료 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
US20170232047A1 (en) * 2012-01-16 2017-08-17 Elizabeth McKenna Control of Cellular Redox Levels
AU2015258769A1 (en) * 2014-05-12 2016-12-01 Medlab Ip Pty Ltd Probiotic compositions and uses thereof for treatment of obesity-related disorders
CN108430482A (zh) * 2015-11-10 2018-08-21 伊丽莎白·麦克纳 细胞氧化还原水平的控制
CN108576822A (zh) * 2018-02-02 2018-09-28 云南中京国建投资有限公司 一种具有增强免疫力功能的合生元组合物及其制剂与应用
WO2021051020A2 (en) * 2019-09-12 2021-03-18 MarvelBiome, Inc. Compositions and methods for characterizing a microbiome
CN111084386A (zh) * 2020-02-28 2020-05-01 大连万众益生大健康有限公司 一种具有改善肠道功能的益生菌补充剂
CN111840335A (zh) * 2020-07-07 2020-10-30 刘平祥 一种含有益生菌的组合物及其在气管炎哮喘上的应用

Also Published As

Publication number Publication date
CN117915934A (zh) 2024-04-19
JP2024524544A (ja) 2024-07-05
EP4366750A1 (en) 2024-05-15
KR20240035481A (ko) 2024-03-15
AU2022305845A1 (en) 2024-01-25
CO2024000934A2 (es) 2024-02-26
CA3223348A1 (en) 2023-01-12
WO2023281335A1 (en) 2023-01-12

Similar Documents

Publication Publication Date Title
Nishito et al. Absorption mechanisms of iron, copper, and zinc: an overview
MX2023014611A (es) Especies, cepas y composiciones de bacterias lacticas capaces de modular la oxigenacion corporal mediante el aumento de los niveles de subunidad alfa del factor 1 inducible por hipoxia (hif-1a).
NZ737752A (en) Compositions comprising bacterial strains
Angulo-Zamudio et al. Lactoferrin disaggregates pneumococcal biofilms and inhibits acquisition of resistance through its DNase activity
Ingle et al. Copper in medicine: Perspectives and toxicity
Nin et al. Effects of hypercapnia in acute respiratory distress syndrome
Legssyer et al. Comparison of injectable iron complexes in their ability to iron load tissues and to induce oxidative stress
MX2007012699A (es) Componenetes lacteos estables eficaces para la perdida de grasa.
BR112015015393A2 (pt) composição para uso como terapia de suporte para tratamento de tumores, aids e leucemia
Dishlyanova et al. Blood haptoglobin response in rabbits with experimentally induced Staphylococcus aureus infection
CA3130389C (en) Composition for use in prevention or reduction of oxidative stress and neurodegenerative diseases
MX2022004799A (es) Composiciones y metodos para el tratamiento de los trastornos de almacenamiento de glucogeno.
Igor et al. Acclimatization to high altitude hypoxia: role of hypoxia mimetic cobalt chloride
IT201900004308U1 (it) Ricetta di un integratore alimentare in forma liquida e adatto a persone che praticano attività sportive.
Bicho et al. SYNTHESIS, CHARACTERIZATION AND STUDY OF THE ANTIMICROBIAL POTENTIAL OF PEPTIDES ANALOGUES TO PEPTIDE (p-BthTX-I) 2
Katoh et al. A soluble cytochrome of the b-type from a green alga, Monostromasp.
Sgibnev et al. Vaginal lactobacilli regulate the activity of muramidase via hydrogen peroxide and surfactants
CN201542046U (zh) 一种矫正坐姿的椅子
Chinvattanachot et al. Mechanisms of Muscle Cells Alterations and Regeneration Decline During Aging
SHOEI et al. Immunochemical studies on bacterial blood group substances. II. Sugar composition of bacteria containing blood group substances
Al-Rikabi et al. Purification of protein lactoferrin from bovine and ovine colostrum and study some properties
Baranskaya et al. Risk of development of secondary alexithymia in depressive patients on hemodialysis
MX2024003664A (es) Composicion fungicida concentrada de azoxistrobina, ciproconazol y clorotalonilo de alta carga, formulaciones y metodo para controlar roya-asiatica y otras enfermedades.
Lucas et al. 6 Arginase and Microbial Pathogenesis in the Lungs
Lutay et al. Effects of intravenous 5 lipoxygenase inhibitor quercetin on endothelial function, systemic inflammation and oxidative stress in acute ST elevation myocardial infarction